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The Homeopathic Effects of Sabal Serrulata against 
Prostate Cancer: an in vitro approach 
Title Dilution Cell lines/strain Main results P value
Effects of Homeopathic Preparations 
on Human Prostate Cancer Growth in 
Cellular and Animal Models
MT
12CH 
30CH
100CH
200CH
300CK 
1000CK
PC-3
DU-145
Male nude BALB/c
nu+ mice
Reduction of cell proliferation (%)
PC-3: 33% at 72h; DU-145: 23% at 24h <0.01; 
<0.01
Tumour incidence (%)
Control: 100%; MT: 94.5%; 200C: 75% -
Reduction of tumour growth: 42% 0.012
Effect of Homeopathic Treatment on 
Gene Expression in Copenhagen Rat 
Tumor Tissues
200C MAT-LyLu
Copenhagen rats
mRNA expression of apoptotic genes: No significant
results
>0.05
Expression of cytokines: No significant results >0.05
Reduction of tumour incidence: 23% -
Reduction of tumour volume: 45% -
Reduction of tumour weight: 33% -
Can Homeopathic Treatment Slow 
Prostate Cancer Growth?
200C DU 145
LNCaP
MAT-LyLu
Copenhagen rats
Cell viability: No significant results >0.05
Apoptotic genes expression: No significant results >0.05
Reduction of tumour incidence: 23% <0.0001
Reduction of tumour volume: 38% <0.02
Reduction of tumour weight: 13% <0.05
Increase of apoptotic cell death: 19% <0.05
Saw Palmetto induces growth arrest 
and apoptosis of androgen-
dependent prostate cancer LNCaP
cells via inactivation of STAT 3 and 
androgen receptor signaling
0.5–1 µl/ml LNCaP Inhibition of cells growth: ED50s=2µl/ml -
Apoptotic effect
0.5µl/ml: 8.7±2.0%(24h); 9.9±1.6%(48h)
1µl/ml: 14.3±2.2%(24h); 35.1±4.4%(48h)
P<0.005
Increase of expression: p21 and p53 -
Down-regulation of IL-6-induced level of pSTAT 3: 60% P<0.005
Inhibition of xenografts growth and weight p<0.05; 
p=0.02
Marina Julià 
Psychosocial context 
surrounding the 
patient
Response
Response results from 
both the specific 
treatment and the 
psychosocial context in 
which it was delivered
Delivery of 
a specific 
treatment 
Environment of the 
treatment
Interaction 
between the 
patient and the 
therapist
Individual factors 
of the patient and 
the therapist
Delivery of 
a Placebo 
Response results from 
the psychosocial 
context surrounding 
the patient  
Mother 
tincture
99 parts
of 
water
Dilution 1C               2C              3C               4C
Concentration 1:102 1:10 4 1:10 6             1:10 8 
Pure 
substance 
Name and potency Dilution Example Meaning Concentration
Mother tincture (MT) P u r e    s u b s t a n c e -
Decimal X or D 1:10 30X 30 consecutive dilutions of 1:10 1:1030
Centesimal C or CH 1:100 30C 30 consecutive dilutions of 1:100 1:1060
Fifty millesimal (LM) 1:50000 30LM 30 consecutive dilutions of 1:50000 1:9.3·10140
1 part 1 part 1 part 1 part
• Principle of similarity. It states that a substance
able to cause a symptom in healthy subjects can
also be used to cure that symptom.
• Principle of infinitesimals. It states that a
therapeutic substance becomes more potent as it is
diluted and vigorous shaken (sucussion).
Placebo effect
In any pharmacologic treatment, the therapeutic effects have
two aspects: specific effects (dosage, duration, interactions,
etc.) and nonspecific effects (expectations and beliefs, non-
pharmacologic characteristics, placebo effect etc.)
Some evidences suggest that the placebo effect is a genuine
psychobiological event conditioned by the overall
therapeutic context (see Figure 3).
In homeopathy, the process of choosing the right medicine for
a patient needs not only a skilled homeopath but also an
open-minded patient willing to present his or her physical
and mental symptoms with a lot of details. Due to this, it has
been hypothesised that:
The placebo phenomenon can have a possible influence on effectiveness rates of homeopathy
Methods
All studies are published in peer-
reviewed journals with impact factor.
The selection criteria required for this
review are:
Objective
Homeopathy in cancer
Prostate cancer is the second most frequent cancer affecting men
(15% of male cancer cases). In Figure 2 there is shown the number
of new cases of prostate cancer on 2006 and 2012.
Sabal Serrulata is a popular phytotherapeutic
agent for the treatment of urologic problems like prostate
cancer. The literature describes various studies in favour
and against Sabal Serrulata’s efficiency (see Figure 5).
In Table 2 are shown the main results obtained and their
possible underlying mechanisms (see Table 2).
Permixon® has an antiproliferative effect against 
prostate cancer cell lines. Some suggested 
mechanisms of action are: 
• Inhibition of both type 1 and type 2 
isoenzymes of 5 alpha-reductase
• Interference with binding of 
dihydrotestosterone to cytosolic androgen 
receptors
• Intrinsic pathway of apoptosis
• Activation of the mitochondrial permeability 
transition pore
• Down-regulation of inflammatory-related 
genes and to the activation of NF-κB pathway
• Changes in cell membrane organisation
A lot of in vitro studies prove many 
effects of Sabal Serrulata against 
different prostatic cancer cell lines.
• Homeopathy one of the most controversial subjects in CAM: the mode of action of the homeopathic potentization is still unknown, the assumptions upon which homeopathy is 
based are not supported from the modern scientific principles and the placebo effect has a possible influence on effectiveness rates of homeopathy. 
• There is a very limited number of reports in the scientific literature. None of the studies are conducted by a blind researcher
• Given the lack of mechanism to explain most of the effects of Sabal Serrulata, any interpretation of these data should be done cautiously. 
• Permixon® could be an interesting tool for new applications such as prostate cancer.
• The administration of Conium maculatum and Thuja Occidentalis along with Sabal serrulata could show more positive effects on cancer. 
o Cytotoxicity measured using MTT assay.
o Anti-proliferative activity measured by trypan blue exclusion assay
o Apoptosis determined by dual staining the cells with ethidium bromide
(EB) and acridine orange (AO) dyes or FACS
o Detection of mRNA expression by ribonuclease protection assay and
multiprobe sets
o Expression of proteins detected by Western blot
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Figure 2: Incidence and Mortality of 
Prostate Cancer on 2006 and 2012
2006 2012
Present an overview about 
current studies that test the 
effects of Sabal Serrulata on 
cells and animal models.
Permixon® is a lipidosterolic extract of Sabal
Serrulata used to treat some of lower urinary
tract symptoms associated with BPH.
Permixon
How to choose the proper treatment?
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IN VITRO STUDIES
Positive results Negative results
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IN VIVO STUDIES
Positive results Negative results
Among prostate cancer patients, approaching 
cancer with homeopathy is becoming 
increasingly popular
This review will focus on the study of Sabal
Serrulata which has effects against prostate pain, 
emission of prostatic secretions and swelling,  
induration and inflammation 
Table 1: Nomenclature of the
most used homeopathic
remedies. Potencies are
abbreviated with a letter. The
number preceding the letter
indicates the number of times
the substance has been diluted.
Figure 1: Process of potentization. 
Figure 5: Number of reviewed studies showing positive and 
negative results about Sabal Serrulata efficiency (in vitro
and in vivo)
This review suggests that due to the lack of consensus, there 
are insufficient scientific evidences to ensure that Sabal
serrulata is the right remedy of choice for prostate cancer
This review will focus on the study of Sabal Serrulata. The choice of this remedy was made following two criteria: 
• Repertory: Index of diseases with its associate symptomatology. Per each
symptom there is a remedy that according to MM fits the most.
• Materia medica (MM): Homeopathic Remedy Reference Guide that lists
all homeopathic remedies with their associated symptomatology.
Figure 3: Contribution of the psychosocial context. 
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Figure 4: Search result from “Syntesis” Repertory
Depending on the patient’s symptomatology 
the therapist has a list of remedies. Among 
them he/she has to choose the most 
suitable/s for the patient.
• It is one of the most prescribed remedies for prostate cancer by the pioneers of homeopathy.
• According to the repertory Synthesis the most suitable remedies for prostate cancer are: Conium Maculatum (CON), Sabal Serrulata
(SABAL) and Thuja Occidentalis (THUJ). (see Figure 4)
The concept 
Homeopathy is a medical system considered as a part of the
Complementary and Alternative Medicine. Samuel Hahnemann is its
founder and he formulated the basic principles in the early 19th century.
Homeopathy is based on two central principles:
Results
Introduction
Conclusions
The homeopathic preparations are done by a
process known as potentization which involves
repeated dilutions with succussion at each step
(see Figure 1).
Table 2: Main results. Studies in favour and against Sabal Serrulata’s efficiency and its possible underlying mechanisms
1. Analyse the in vitro studies published in scientific sources that
evaluate the effectiveness of Sabal serrulata.
2. The administration of the drug to cells will fully minimise the
possible placebo effect observed in patients. Therefore, the
specific therapeutic effects of the drugs will be demonstrated.
3. In vivo studies with animal models will complement
in vitro studies.
Homeopathic Medicines Do Not Alter 
Growth and Gene Expression in 
Prostate and Breast Cancer Cells In 
Vitro
30C
200C
1000C
MAT-LyLu
MDA-MB-231
Cell growth and viability: No significant results >0.05
mRNA expression of apoptotic genes: No significant
results
>0.05
Schroyens F., Synthesis 9.2 (Spanish-English)
PROSTATE GLAND
PRÓSTATA
CANCER of prostate
CANCER de próstata: (22) bar-ox-suc. carc. chim. CON. Cop.           
crot-h. lod. kali-cy. Lyc. naphthoq. plb. Psor. SABAL Scir. Sel. 
senec. Sil. staph. sulfonam. Sulph. THUJ. thymol
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